N. Wassef

发表

Adjuvant effects of liposomes containing lipid A: enhancement of liposomal antigen presentation and recruitment of macrophages

C. Alving, S. Amselem, J. N. Verma, 1992, Infection and immunity.

Liposomes Containing Lipid A Serve as an Adjuvant for Induction of Antibody and Cytotoxic T-Cell Responses against RTS,S Malaria Antigen

C. Alving, G. Glenn, R. Richards, 1998, Infection and Immunity.

Complement activation in vitro by the red cell substitute, liposome‐ encapsulated hemoglobin: mechanism of activation and inhibition by soluble complement receptor type 1

C. Alving, J. Szebeni, A. Rudolph, 1997, Transfusion.

Immunization with cholesterol-rich liposomes induces anti-cholesterol antibodies and reduces diet-induced hypercholesterolemia and plaque formation.

R. Virmani, F. Kolodgie, J. Cornhill, 1996, The Journal of laboratory and clinical medicine.

Effects of negatively charged lipids on phagocytosis of liposomes opsonized by complement.

C. Alving, F. Roerdink, N. Wassef, 1983, Biochimica et biophysica acta.

Complement-dependent phagocytosis of liposomes.

C. Alving, N. Wassef, 1993, Chemistry and physics of lipids.

Trafficking of liposomal antigen to the trans-Golgi of murine macrophages requires both liposomal lipid and liposomal protein.

C. Alving, M. Rao, N. Wassef, 1999, Experimental cell research.

Complement activation by liposome-encapsulated hemoglobin in vitro: the role of endotoxin contamination.

C. Alving, J. Szebeni, A. Rudolph, 1995, Artificial cells, blood substitutes, and immobilization biotechnology.

Complement-Dependent Phagocytosis of Liposomes: Suppression by “Stealth” Lipids

C. Alving, N. Wassef, 1992 .

Complement-dependent phagocytosis of liposomes by macrophages: suppressive effects of "stealth" lipids.

G. Matyas, C. Alving, N. Wassef, 1991, Biochemical and biophysical research communications.

Phosphatidylinositol liposomes opsonized by concanavalin A stimulate phosphatidylinositol turnover in macrophages.

C. Alving, N. Wassef, 1986, Biochemical and biophysical research communications.

Complement-dependent phagocytosis of liposomes by macrophages.

C. Alving, N. Wassef, 1987, Methods in enzymology.

Cross-reactions of nucleic acids with monoclonal antibodies to phosphatidylinositol phosphate and cholesterol.

C. Alving, B. Stollar, G. Swartz, 1989, Molecular immunology.

Naturally occurring antibodies to cholesterol: a new theory of LDL cholesterol metabolism.

C. Alving, N. Wassef, 1999, Immunology today.

Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide.

G. Matyas, C. Alving, B. Brandt, 2012, Vaccine.

Detection of antibodies to squalene: III. Naturally occurring antibodies to squalene in humans and mice.

G. Matyas, C. Alving, M. Rao, 2004, Journal of immunological methods.

Prostaglandin and thromboxane in liposomes: suppression of the primary immune response to liposomal antigens.

C. Alving, R. Richards, M. Hayre, 1989, Biochemical and biophysical research communications.

Cytokines as adjuvants for HIV DNA vaccines

S. Plaeger, N. Wassef, 2002 .

Antibodies to cholesterol: biological implications of antibodies to lipids.

M. Potter, C. Alving, N. Wassef, 1996, Current topics in microbiology and immunology.

Preparation and Use of Liposomes in Immunological Studies

C. Alving, I. Mattsby‐Baltzer, R. Richards, 1993 .

Anaphylactoid reactions mediated by autoantibodies to cholesterol in miniature pigs.

C. Alving, D. Taylor, J. R. Hailey, 1989, Journal of immunology.

Naturally occurring autoantibodies to cholesterol in humans.

C. Alving, G. Swartz, N. Wassef, 1989, Biochemical Society transactions.

Visualization of peptides derived from liposome-encapsulated proteins in the trans-Golgi area of macrophages.

C. Alving, R. Pagano, M. Rao, 1997, Immunology letters.

Liposomes as carriers for vaccines.

C. Alving, R. Richards, N. Wassef, 1994, ImmunoMethods.

Immunized with Oligomeric gp160 Respiratory Tracts of Mice Intranasally HIV-1 Neutralizing Antibodies in the Genital and

J. Mascola, D. Birx, C. Alving, 1998 .

Toxic effects of antileishmanial reverse-phase evaporation liposomes containing dicetyl phosphate in monkeys

J. Berman, C. Alving, C. Wilhelmsen, 1995 .

Phagocytosis of liposomes by macrophages: intracellular fate of liposomal malaria antigen.

C. Atkinson, R. Wirtz, C. Alving, 1991, Biochimica et biophysica acta.

Liposomes : Role of Complement and Inhibition by Soluble CR 1 and AntiC 5 a Hemoglobin in Pigs : A Model for Pseudoallergic Cardiopulmonary Reactions to Hemodynamic Changes Induced by Liposomes and Liposome-Encapsulated

C. Alving, J. Szebeni, R. Bünger, 1999 .

Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody.

J Szebeni, C. Alving, J. Szebeni, 1999, Circulation.

HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160.

J. Mascola, D. Birx, C. Alving, 1998, Journal of immunology.

Phosphate-binding specificities of monoclonal antibodies against phosphoinositides in liposomes.

C. Alving, F. Roerdink, J. Lyon, 1984, Molecular immunology.

Inhibition of growth in young mice treated with pentazocine: reversal by naltrexone.

A. Smith, N. Wassef, 1980, European journal of pharmacology.

GROWTH INHIBITION INDUCED BY METHADONE: PREVENTION BY DIBUTYRYL CYCLIC ADENOSINE MONOPHOSPHATE

N. Wassef, Alfred A. Smith, 1980 .

Liposomal subunit vaccines: effects of lipid A and aluminum hydroxide on immunogenicity.

C. Alving, R. Richards, N. Wassef, 1996, Journal of pharmaceutical sciences.

Induction and detection of antibodies to squalene.

G. Matyas, C. Alving, M. Rao, 2000, Journal of immunological methods.

Neutralization of a clade B primary isolate by sera from human immunodeficiency virus-uninfected recipients of candidate AIDS vaccines.

K. Steimer, S. Zolla-Pazner, M. McElrath, 1997, The Journal of infectious diseases.

ATP specifically bound as a hapten to a monoclonal anti-phospholipid antibody retains phosphate donor activity.

C. Alving, G. Swartz, N. Wassef, 1993, Biochemical and biophysical research communications.

A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge

N. Letvin, E. Emini, R. Woods, 1995, Journal of virology.

Proteasome inhibitors block the entry of liposome-encapsulated antigens into the classical MHC class I pathway.

C. Alving, M. Rao, N. Wassef, 2000, Immunology letters.

Specific binding of concanavalin A to free inositol and liposomes containing phosphatidylinositol.

C. Alving, N. Wassef, E. C. Richardson, 1985, Biochemical and biophysical research communications.

Prospects for an Anticholesterol Vaccine

R. Virmani, F. Kolodgie, J. Cornhill, 1995, Clinical Immunotherapeutics.

Intracellular processing of liposome-encapsulated antigens by macrophages depends upon the antigen

C. Alving, M. Rao, U. Krzych, 1995, Infection and immunity.

Modulation of phosphatidylinositol turnover by liposomes containing phosphatidylinositol.

C. Alving, N. Wassef, 1987, Methods in enzymology.

Complement activation and thromboxane secretion by liposome-encapsulated hemoglobin in rats in vivo: inhibition by soluble complement receptor type 1.

C. Alving, J. Szebeni, A. Rudolph, 1997, Artificial cells, blood substitutes, and immobilization biotechnology.

Complement activation in rats by liposomes and liposome-encapsulated hemoglobin: evidence for anti-lipid antibodies and alternative pathway activation.

C. Alving, J. Szebeni, A. Rudolph, 1994, Biochemical and biophysical research communications.

Complement activation in human serum by liposome-encapsulated hemoglobin: the role of natural anti-phospholipid antibodies.

C. Alving, J. Szebeni, A. Rudolph, 1996, Biochimica et biophysica acta.

Suppression of phagocytic function and phospholipid metabolism in macrophages by phosphatidylinositol liposomes.

C. Alving, F. Roerdink, N. Wassef, 1984, Proceedings of the National Academy of Sciences of the United States of America.

Liposomes containing lipid A as a potent non-toxic adjuvant.

S. Green, C. Alving, S. Amselem, 1992, Research in immunology.

Antibody and cytotoxic T-lymphocyte responses to a single liposome-associated peptide antigen.

R. Woods, W. White, S. Burke, 1995, Vaccine.

Viral reservoirs/transient infection in HIV/AIDS: where are we now and where should we go? Summary of the June 13-14, 2002 Think Tank meeting.

N. Wassef, Roger H. Miller, J. Young, 2003, AIDS research and human retroviruses.

Cytotoxic T lymphocytes induced by liposomal antigens: mechanisms of immunological presentation.

C. Alving, N. Wassef, 1994, AIDS Research and Human Retroviruses.